Hematology/Oncology News

The FDA expanded the approval of nivolumab for treatment of non-small cell lung cancer.

CHICAGO — In this Healio video exclusive, Hansa Bhargava, MD, talks with Eve Bloomgarden, MD, about finding and following your passions, and the importance of obtaining a different perspective at the Women in Medicine Summit.

Extended lymphadenectomy offered no survival benefit for patients with localized muscle-invasive bladder cancer compared with bilateral standard lymphadenectomy for patients undergoing radical cystectomy, according to study findings.

In this episode, host Shikha Jain, MD, speaks with Annmarie Ison about developing safe and accurate software, how software can improve health care disparities and more.

The FDA has granted 510(k) clearance to qCT LN Quant, an AI solution that aids clinicians in finding lung nodule diameters, malignancy risk and management approaches, according to a manufacturer-issued press release.

Every October marks Liver Cancer Awareness Month in an effort to raise awareness and improve advocacy and treatment for patients living with the disease.

Digital patient-facing technologies over the past decade have improved the coordination and delivery of oncology care, but they have the potential to overwhelm patients, according to a commentary published in JCO Clinical Cancer Informatics.

Delays in cancer registration may have underestimated 10-year colorectal cancer risk reductions by up to 75% in the NordICC trial, with researchers warning that study estimates on screening colonoscopy should be “interpreted with caution.”

In a video interview, Nancy Lin, MD, of Dana-Farber Cancer Institute, talked about an analysis of HERA trial data presented at ESMO Congress.

In a video interview, Nancy Lin, MD, of Dana-Farber Cancer Institute, discussed “interesting updates” from the NATALEE trial presented at ESMO Congress.